Table 3.
Antibiotics resistance patterns of GPB, HUCSH, and Southern Ethiopia
| Antibiotics | S. aureus (156) | CoNS (64) | Enterococcus spp(31) | S. pneumoniae (7) | Total |
|---|---|---|---|---|---|
| R (%) | R (%) | R (%) | R (%) | R (%) | |
| AMP | NR | NR | 20(74.1) | NR | 20(74.1) |
| GEN | 42(31.8) | 32(55.2) | NR | NR | 74(38.9) |
| COT | 61(73.5) | 49(90.7) | NR | 4(66.7) | 116(81.1) |
| PEN | 41(80.4) | 24(92.3) | 6(75) | 1(33.3) | 72(81.8) |
| CAF | 22(19.5) | 22(40.7) | 8(34.8) | 3(60) | 55(28.2) |
| CLD | 2(5.3) | ND | NR | NR | 2(5.3) |
| NOR | 15(65.2) | 3(33.3) | 10(83.3) | NR | 28(63.6) |
| NIT | 1(14.3) | ND | 1(12.5) | NR | 2(13.3) |
| ERY | 20(31.7) | 9(50) | 11(73.3) | 0(0) | 40(40.4) |
| TAT | 11(61.1) | ND | 3(100) | 0(0) | 14(63.6) |
| CIP | 42(31.8) | 27(46.6) | 19(76) | NR | 88(40.9) |
| AUG | 51(52) | 24(39.3) | NR | NR | 75(47.2) |
| CTR | 39(45.3) | 22(41.5) | NR | NR | 61(43.9) |
| CAZ | 27(58.7) | 31(79.5) | NR | ND | 58(68.2) |
NR- Not recommended, ND-not done, R-Resistance, T- total tested, CoNS- coagulase-negative staphylococcus, ampicillin (AMP)(10 μg), gentamicin-Gen(10 μg), ciprofloxacin-CRP(5 μg), ceftriaxone-CRT(30 μg), ceftazidime-CAZ(30 μg), norfloxacin-NOR)(10 μg), nitrofurantoin-NIT(300 μg), augmentin-AUG(20/10 μg), cotrimoxazole-COT(1.25/23.75 μg), chloramphenicol-CAF(30 μg), meropenem-MER(10 μg), tetracycline-TAT(30 μg), penicillin G-PEN(10 IU), Clindamycin-CLD(2 μg) and erythromycin-ERY(15 μg).